Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis

Cancer Science

Volumn 98, Issue 12, 2007, Pages 1875-1880

  Shimizu, Kei ^a,b   Karube, Kennosuke ^a   Arakawa, Fumiko ^a   Nomura, Yuko ^c   Komatani, Hideki ^a   Yamamoto, Kouhei ^d   Yoshida, Shiro ^a   Aoki, Ryosuke ^a   Sugita, Yasuo ^a   Takeshita, Morishige ^c   Ohshima, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCL18 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CX3C CHEMOKINE RECEPTOR 1; DNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LEUKEMOGENESIS; LYMPHADENITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; TH1 CELL; TH2 CELL; UPREGULATION;

CHEMOKINES, CC; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPH NODES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; UP-REGULATION;

EID: 35548954105     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00627.x     Document Type: Article

References (30)

1. Takatsuki K. Overview of adult T-cell leukemia/lymphoma. Jpn Soc Res 1985; 25: 97-103.
2. Kikuchi M, Mitsui T, Eimoto T, Toyooka R, Nishiuchi M. Biopsy of adult T cell leukemia. Gann Mono Can Res 1982; 28: 37-50.
3. Ohshima K, Suzumiya J, Sato K et al. Survival of patients with HTLV-I-associated lymph node lesions. J Pathol 1999; 189: 539-45.
4. Ohshima K, Kikuchi M, Masuda Y et al. HTLV-I associated lymphadenitis. Cancer 1992; 69: 239-48.
5. Ohshima K, Kikuchi M, Yoshida T, Masuda Y, Kimura N. Lymph node in incipient adult T-cell leukemia lymphoma with Hodgkin's disease-like histologic features. Cancer 1991; 67: 1622-8.
6. + T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features. Int J Cancer 1997; 72: 592-8.
7. Yoshie O, Fujisawa R, Nakayama T et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002; 99: 1505-11.
8. Hasegawa H, Nomura T, Kohno M et al. Increased chemokine receptor CCR7/ EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood 2000; 95: 30-8.
9. Mori N, Krensky AM, Ohshima K et al. Elevated expression of CCL5/RANTES in adult T-cell leukemia cells: Possible transactivation of the CCL5 gene by human T-cell leukemia virus type I Tax. Int J Cancer 2004; 111: 548-57.
10. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-70.
11. Heller RA, Schena M, Chai A et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 1997; 94: 2150.
12. Backert S, Gelos M, Kobalz U et al. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. Int J Cancer 1999; 82: 868-74.
13. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
14. Ohshima K, Suzumiya J, Sato K et al. Nodal T-cell lymphoma in an HTLV-I-endemic area: Proviral HTLV-I DNA, histological classification and clinical evaluation. Br J Haematol 1998; 101: 703-11.
15. Tsuchiya T, Ohshima K, Karube K et al. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: Comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood 2004; 103: 236-41.
16. Ohshima K, Kikuchi M, Masuda Y et al. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features. Cancer Res 1991; 51: 4639-42.
17. Eisen MB, Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol 1999; 303: 179-205.
18. Ohshima K, Suzumiya J, Izumo S, Mukai Y, Tashiro K, Kikuchi M. Detection of human T-lymphotrophic virus type-I DNA and mRNA in the lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH). Int J Cancer 1996; 66: 18-23.
19. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005; 24: 6047-57.
20. Imai T, Nishimura M, Nanki T, Umehara H. Fractalkine and inflammatory disease. Jpn J Clin Immunol 2005; 28: 131-9.
21. + cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002; 168: 6173-80.
22. Kannagi M, Matsushita S, Shida H, Harada S. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia 1994; 8 (Suppl 1): S54-9.
23. Kannagi M, Sugamura K, Kinoshita K, Uchino H, Hinuma Y. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J Immunol 1984; 133: 1037-41.
24. Karube K, Ohshima K, Tsuchiya T et al. Expression of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T cell leukemia/ lymphoma cells. Br J Haematol 2004; 126: 81-4.
25. Suefuji H, Ohshima K, Hayabuchi N, Nakamura K, Kikuchi M. HTLV-1 carriers with B-cell lymphoma. Prognosis, clinical and immunopathological features. Br J Haematol 2003; 123: 606-12.
26. Struyf S, Schutyser E, Gouwy M et al. PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia. Am J Pathol 2003; 163: 2065-75.
27. Leung SY, Yuen ST, Chu KM et al. Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology 2004; 127: 457-69.
28. Schutyser E, Struyf S, Proost P et al. Identification of biologically active chemokine isoforms from ascetic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem 2002; 277: 24 584-93.
29. Schutyser E, Richmond A, Damme JV. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J Leukoc Biol 2005; 78: 14-26.
30. Yano H, Ishida T, Inagaki A et al. Regulatory T-cell function of adult T-cell leukemia/lymphoma cells. Int J Cancer 2007; 120: 2052-7.